Cancer BiologyBritish Journal of CancerPeer-reviewed
NEK9 ablation rewires docetaxel resistance through induction of ERK-mediated cancer cell pyroptosis
Shamima Azma Ansari, Sibasish Mohanty, Pallavi Mohapatra…·Rupesh Dash
This study identifies NEK9 as a driver of docetaxel resistance in cancers and shows that its ablation sensitizes cells to docetaxel via ERK-mediated pyroptosis, suggesting fostamatinib as a potential therapeutic partner.
3 citations